- dentalcorp Holdings Ltd DNTL coverage has been assumed with a Buy recommendation and a price target of C$21 by Desjardins analyst Gary Ho.
- The analyst says the recently announced dental care proposal for low-income Canadians as a slight benefit for the company.
- The analyst sees the business model offering downside protection through >80% recurring patients/revenue, a non-discretionary spend and cash-pay arrangement with minimal credit risk, as well as upside growth from M&A and organic growth.
- The analyst states that DNTL’s management team has a successful M&A track record of acquiring, integrating, and retaining >180 practice additions in the past three years despite COVID-19 restrictions.
- Price Action: DNTL shares are trading lower by 1.36% at C$15.26 on TSX on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
